Yuri Hiramatsu

Iizuka, 8200018, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study.

Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study.

Journal: Respiratory investigation
Published: May 01, 2026

FDG Uptake in WT1 Peptide Vaccination Adjuvant-induced Granuloma: A 93-month Follow-up.

FDG Uptake in WT1 Peptide Vaccination Adjuvant-induced Granuloma: A 93-month Follow-up.

Journal: Clinical nuclear medicine
Published: February 15, 2026

Sarcomatoid Lung Carcinoma Successfully Treated With Combined Cytotoxic Chemotherapy and Anti-Programmed Death-Ligand 1 (Anti-PD-L1) Antibodies.

Sarcomatoid Lung Carcinoma Successfully Treated With Combined Cytotoxic Chemotherapy and Anti-Programmed Death-Ligand 1 (Anti-PD-L1) Antibodies.

Journal: Cureus
Published: October 27, 2025

Fatal Postoperative Pulmonary Tumor Thrombotic Microangiopathy: A Rare and Fulminant Complication of Large Cell Lung Carcinoma.

Fatal Postoperative Pulmonary Tumor Thrombotic Microangiopathy: A Rare and Fulminant Complication of Large Cell Lung Carcinoma.

Journal: Cureus
Published: October 04, 2025

Ultrasound-guided percutaneous core biopsy of thoracic lesions: Diagnostic yield and site-specific safety.

Ultrasound-guided percutaneous core biopsy of thoracic lesions: Diagnostic yield and site-specific safety.

Journal: Respiratory investigation
Published: August 27, 2025

Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study.

Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study.

Journal: Rheumatology (Oxford, England)
Published: June 17, 2025

Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study.

Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study.

Journal: Rheumatology (Oxford, England)
Published: April 22, 2025

Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.

Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.

Journal: Rheumatology (Oxford, England)
Published: November 15, 2024

Immunoglobulin A Vasculitis After Initiation of Treatment for Tuberculous Pleurisy: A Case Report and Literature Review.

Immunoglobulin A Vasculitis After Initiation of Treatment for Tuberculous Pleurisy: A Case Report and Literature Review.

Journal: Cureus
Published: April 20, 2024

Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus.

Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus.

Journal: Modern rheumatology
Published: January 30, 2024

Nodular pulmonary amyloidosis diagnosed by ultrasound-guided percutaneous needle biopsy.

Nodular pulmonary amyloidosis diagnosed by ultrasound-guided percutaneous needle biopsy.

Journal: Respiratory medicine case reports
Published: January 16, 2024

Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.

Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.

Journal: International journal of rheumatic diseases
Published: December 03, 2023
Showing 1-12 of 31

Last Updated: 09/26/2026